{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-007597","form_type":"8-K","ticker":"MGRX","cik":"0001938046","company_name":"MANGOCEUTICALS, INC.","filed_at":"2025-02-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.607064+00:00","generated_at":"2026-05-26T12:33:15.793599+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Mangoceuticals enters advisory consulting agreement and receives $120K from warrant exercise","bullets":["Issued 200,000 restricted shares to 6330 Investment & Consulting for 12-month strategic advisory services.","Received $120,000 aggregate exercise price for 80,000 shares from a warrant holder at $1.50 per share.","Consultant will provide introductions for strategic partners and M&A opportunities; estimated 10 hours/week.","Shares issued under Section 4(a)(2) exemption; no public offering or underwriting."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-007597","json":"https://secwatch.observer/filing/0001493152-25-007597.json","markdown":"https://secwatch.observer/filing/0001493152-25-007597.md","text":"https://secwatch.observer/filing/0001493152-25-007597.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1938046/000149315225007597/0001493152-25-007597-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1938046/000149315225007597/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T12:33:15.793599+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}